NPPA extends date for submitting price-related data for non-scheduled Medical Devices Medical Dialogues Team14 March 2021 10:00 AM ISTNew Delhi: In response to requests from various companies and industry associations for an extension of the date for submitting price-related data for...
Citing voglibose, sitagliptin incompatibility, CDSCO panel rejects Hetero Labs proposal for antidiabetic FDC drug Medical Dialogues Team13 March 2021 6:50 PM ISTNew Delhi: In a setback to Hetero Labs, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO)...
Sun Pharma secures CDSCO panel nod for Dextromethorphan Hydrobromide, Chlorpheniramine maleate FDC Medical Dialogues Team12 March 2021 6:47 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under Central Drugs Standard Control Organization (CDSCO) has given its nod to Sun...
CDSCO Committee recommends Bharat Biotech to drop clinical trial mode label for Covaxin Medical Dialogues Team11 March 2021 2:55 PM ISTNew Delhi: In order to boost the acceptance of indigenously developed Bharat Biotech's Covid-19 vaccine, the Subject Expert Committee (SEC) committee...
Issuance of Registration Certificate, Import License for Veterinary Vaccines: CDSCO asks SLAs for e-submission of applications Medical Dialogues Team11 March 2021 1:00 PM ISTNew Delhi: In order to streamline the regulatory submission procedure, the Central Drugs Standard Control Organization (CDSCO) (Veterinary Division)...
CDSCO declares 16 drug samples including Clopidogrel, Aspirin Tablets as Not of Quality Standard Medical Dialogues Team10 March 2021 4:55 PM ISTNew Delhi: The apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has flagged 16 drug samples including Clopidogrel and...
Etanercept in COVID19 patients: CDSCO Committee tells Lupin to submit revised phase 2 CT protocol Medical Dialogues Team9 March 2021 5:40 PM ISTNew Delhi: The Subject Expert Committee (SEC), functional under Central Drug Standard Organization (CDSCO), has recently suggested drug major Lupin...
CDSCO asks Akums Drugs to revise phase III CT protocol for abortion drug Mifepristone Medical Dialogues Team8 March 2021 6:46 PM ISTNew Delhi: Recommending to exclude patients using any contraceptive method other than conventional methods, barrier, male or female sterilization, the...
February 2021 turned out to be slow month for Indian Pharma: AIOCD-AWACS data Medical Dialogues Team7 March 2021 2:36 PM ISTNew Delhi: COVID crisis showed a negative impact on the Indian pharmaceutical market (IPM) in February as the recent data from market research firm...
Rationality of FDC drugs: DTAB Sub Committee invites stakeholders for hearing Medical Dialogues Team6 March 2021 2:23 PM ISTDTAB has invited the concerned stakeholders for hearing with effect from 19.04.2021. It has also been notified that the schedule of hearing will be...
Serum Institute of India writes to PMO recommending reforms in drug regulatory system Ruchika Sharma5 March 2021 1:01 PM IST"In view of the successful result of this provision for COVID-19 vaccine, this provision should also be implemented for non-COVID-19 vaccines," Singh...
HC asks Serum Institute, Bharat Biotech to disclose Covid vaccines manufacturing capacity Ruchika Sharma4 March 2021 6:00 PM ISTNew Delhi: The Delhi High Court Thursday directed Serum Institute of India and Bharat Biotech to disclose their capacities to manufacture Covaxin,...
